Johnson & Johnson partnered with a startup company to study gut bacteria in hopes of developing drugs for bowel disease.
Terms of the deal between J&J’s Janssen Biotech and Second Genome weren’t disclosed. San Bruno, California-based Second Genome concentrates on...






![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
